Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001308411-13-000127
Filing Date
2013-05-07
Accepted
2013-05-07 16:25:16
Documents
10
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 TAMIR BIOTECHNOLOGY, INC. FORM 10-Q JANUARY 31, 2012 acelform10q120131.htm 10-Q 278098
2 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 11367
3 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 11384
4 EXHIBIT 32 exhibit32.htm EX-32 5320
  Complete submission text file 0001308411-13-000127.txt   2134957

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE acel-20120131.xml EX-101.INS 251360
6 XBRL SCHEMA FILE acel-20120131.xsd EX-101.SCH 15411
7 XBRL CALCULATION FILE acel-20120131_cal.xml EX-101.CAL 38778
8 XBRL DEFINITION FILE acel-20120131_def.xml EX-101.DEF 11552
9 XBRL LABEL FILE acel-20120131_lab.xml EX-101.LAB 140301
10 XBRL PRESENTATION FILE acel-20120131_pre.xml EX-101.PRE 98599
Mailing Address 300 ATRIUM DRIVE SOMERSET NJ 08873
Business Address 300 ATRIUM DRIVE SOMERSET NJ 08873 732-652-4525
Tamir Biotechnology, Inc. (Filer) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-11088 | Film No.: 13820355
SIC: 2836 Biological Products, (No Diagnostic Substances)